261 related articles for article (PubMed ID: 24374212)
1. Differential effects of epigenetic modifiers on the expansion and maintenance of human cord blood stem/progenitor cells.
Mahmud N; Petro B; Baluchamy S; Li X; Taioli S; Lavelle D; Quigley JG; Suphangul M; Araki H
Biol Blood Marrow Transplant; 2014 Apr; 20(4):480-9. PubMed ID: 24374212
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo expansion of human mobilized peripheral blood stem cells using epigenetic modifiers.
Saraf S; Araki H; Petro B; Park Y; Taioli S; Yoshinaga KG; Koca E; Rondelli D; Mahmud N
Transfusion; 2015 Apr; 55(4):864-74. PubMed ID: 25363624
[TBL] [Abstract][Full Text] [Related]
3. Cord blood stem cell expansion is permissive to epigenetic regulation and environmental cues.
Araki H; Baluchamy S; Yoshinaga K; Petro B; Petiwala S; Parajuli R; Milhem M; Lavelle D; DeSimone J; Mahmud N
Exp Hematol; 2009 Sep; 37(9):1084-95. PubMed ID: 19501128
[TBL] [Abstract][Full Text] [Related]
4. Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents.
Araki H; Mahmud N; Milhem M; Nunez R; Xu M; Beam CA; Hoffman R
Exp Hematol; 2006 Feb; 34(2):140-9. PubMed ID: 16459182
[TBL] [Abstract][Full Text] [Related]
5. Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential.
Araki H; Yoshinaga K; Boccuni P; Zhao Y; Hoffman R; Mahmud N
Blood; 2007 Apr; 109(8):3570-8. PubMed ID: 17185465
[TBL] [Abstract][Full Text] [Related]
6. Expansion and preservation of the functional activity of adult hematopoietic stem cells cultured ex vivo with a histone deacetylase inhibitor.
Zimran E; Papa L; Djedaini M; Patel A; Iancu-Rubin C; Hoffman R
Stem Cells Transl Med; 2020 Apr; 9(4):531-542. PubMed ID: 31950644
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitors induce leukemia gene expression in cord blood hematopoietic stem cells expanded ex vivo.
Lam YM; Chan YF; Chan LC; Ng RK
Int J Hematol; 2017 Jan; 105(1):37-43. PubMed ID: 27531147
[TBL] [Abstract][Full Text] [Related]
8. Modification of hematopoietic stem cell fate by 5aza 2'deoxycytidine and trichostatin A.
Milhem M; Mahmud N; Lavelle D; Araki H; DeSimone J; Saunthararajah Y; Hoffman R
Blood; 2004 Jun; 103(11):4102-10. PubMed ID: 14976039
[TBL] [Abstract][Full Text] [Related]
9. Chromatin-Modifying Agent-Expanded Human Cord Blood Cells Display Reduced Allostimulatory Capacity.
Petro B; Mahmud D; Taioli S; Ganapathy A; Senyuk V; Yoshinaga KG; Suphangul M; Rondelli D; Mahmud N
J Immunol; 2019 Apr; 202(8):2493-2501. PubMed ID: 30842275
[TBL] [Abstract][Full Text] [Related]
10. Chromatin-modifying agents promote the ex vivo production of functional human erythroid progenitor cells.
Chaurasia P; Berenzon D; Hoffman R
Blood; 2011 Apr; 117(17):4632-41. PubMed ID: 21355088
[TBL] [Abstract][Full Text] [Related]
11. Role of epigenetic reprogramming in hematopoietic stem cell function.
Iancu-Rubin C; Hoffman R
Curr Opin Hematol; 2015 Jul; 22(4):279-85. PubMed ID: 26049747
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic reprogramming induces the expansion of cord blood stem cells.
Chaurasia P; Gajzer DC; Schaniel C; D'Souza S; Hoffman R
J Clin Invest; 2014 Jun; 124(6):2378-95. PubMed ID: 24762436
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic repopulating ability of CD34⁺ progenitor cells ex vivo expanded with different cytokine combinations.
Du Z; Jin H; Cai H; Yang S; Tan WS
Artif Cells Nanomed Biotechnol; 2015; 43(6):398-402. PubMed ID: 24665846
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic and molecular signatures of cord blood CD34(+) cells treated with histone deacetylase inhibitors.
Gajzer D; Ross J; Winder L; Navada S; Zhang W; Silverman L; Chaurasia P
Vox Sang; 2016 Jan; 110(1):79-89. PubMed ID: 26084882
[TBL] [Abstract][Full Text] [Related]
15. Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cells.
Wang X; Zhang W; Tripodi J; Lu M; Xu M; Najfeld V; Li Y; Hoffman R
Blood; 2010 Dec; 116(26):5972-82. PubMed ID: 20858855
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal.
Young JC; Wu S; Hansteen G; Du C; Sambucetti L; Remiszewski S; O'Farrell AM; Hill B; Lavau C; Murray LJ
Cytotherapy; 2004; 6(4):328-36. PubMed ID: 16146885
[TBL] [Abstract][Full Text] [Related]
17. Effects of chromatin-modifying agents on CD34+ cells from patients with idiopathic myelofibrosis.
Shi J; Zhao Y; Ishii T; Hu W; Sozer S; Zhang W; Bruno E; Lindgren V; Xu M; Hoffman R
Cancer Res; 2007 Jul; 67(13):6417-24. PubMed ID: 17616702
[TBL] [Abstract][Full Text] [Related]
18. Valproic acid enhances the engraftability of human umbilical cord blood hematopoietic stem cells expanded under serum-free conditions.
Seet LF; Teng E; Lai YS; Laning J; Kraus M; Wnendt S; Merchav S; Chan SL
Eur J Haematol; 2009 Feb; 82(2):124-32. PubMed ID: 19067743
[TBL] [Abstract][Full Text] [Related]
19. Zebrafish In-Vivo Screening for Compounds Amplifying Hematopoietic Stem and Progenitor Cells: - Preclinical Validation in Human CD34+ Stem and Progenitor Cells.
Arulmozhivarman G; Kräter M; Wobus M; Friedrichs J; Bejestani EP; Müller K; Lambert K; Alexopoulou D; Dahl A; Stöter M; Bickle M; Shayegi N; Hampe J; Stölzel F; Brand M; von Bonin M; Bornhäuser M
Sci Rep; 2017 Sep; 7(1):12084. PubMed ID: 28935977
[TBL] [Abstract][Full Text] [Related]
20. Valproic acid affects the engraftment of TPO-expanded cord blood cells in NOD/SCID mice.
Vulcano F; Milazzo L; Ciccarelli C; Barca A; Agostini F; Altieri I; Macioce G; Di Virgilio A; Screnci M; De Felice L; Giampaolo A; Hassan HJ
Exp Cell Res; 2012 Feb; 318(4):400-7. PubMed ID: 22166516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
